Arecor Therapeutics (AREC) Competitors GBX 44.50 +1.00 (+2.30%) As of 07/4/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesBuy This Stock AREC vs. REDX, ETX, SBTX, COS, C4XD, DDDD, TRX, FUM, OKYO, and AORShould you be buying Arecor Therapeutics stock or one of its competitors? The main competitors of Arecor Therapeutics include Redx Pharma (REDX), e-therapeutics (ETX), SkinBioTherapeutics (SBTX), Collagen Solutions plc (COS.L) (COS), C4X Discovery (C4XD), 4D pharma (DDDD), Tissue Regenix Group (TRX), Futura Medical (FUM), OKYO Pharma (OKYO), and AorTech International (AOR). These companies are all part of the "biotechnology" industry. Arecor Therapeutics vs. Its Competitors Redx Pharma e-therapeutics SkinBioTherapeutics Collagen Solutions plc (COS.L) C4X Discovery 4D pharma Tissue Regenix Group Futura Medical OKYO Pharma AorTech International Arecor Therapeutics (LON:AREC) and Redx Pharma (LON:REDX) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their valuation, risk, profitability, institutional ownership, media sentiment, earnings, dividends and analyst recommendations. Is AREC or REDX more profitable? Redx Pharma has a net margin of 0.00% compared to Arecor Therapeutics' net margin of -176.89%. Arecor Therapeutics' return on equity of -118.67% beat Redx Pharma's return on equity.Company Net Margins Return on Equity Return on Assets Arecor Therapeutics-176.89% -118.67% -37.31% Redx Pharma N/A -180.80%-43.95% Which has stronger earnings & valuation, AREC or REDX? Arecor Therapeutics has higher revenue and earnings than Redx Pharma. Arecor Therapeutics is trading at a lower price-to-earnings ratio than Redx Pharma, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioArecor Therapeutics£6.04M2.78-£10.68M-£28.30-1.57Redx Pharma£4.20M0.00-£33.16M-£0.10N/A Do insiders & institutionals have more ownership in AREC or REDX? 44.1% of Arecor Therapeutics shares are owned by institutional investors. Comparatively, 72.7% of Redx Pharma shares are owned by institutional investors. 25.3% of Arecor Therapeutics shares are owned by company insiders. Comparatively, 18.4% of Redx Pharma shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth. Which has more risk and volatility, AREC or REDX? Arecor Therapeutics has a beta of -0.18, suggesting that its stock price is 118% less volatile than the S&P 500. Comparatively, Redx Pharma has a beta of -0.53, suggesting that its stock price is 153% less volatile than the S&P 500. Does the media prefer AREC or REDX? In the previous week, Arecor Therapeutics' average media sentiment score of 0.00 equaled Redx Pharma'saverage media sentiment score. Company Overall Sentiment Arecor Therapeutics Neutral Redx Pharma Neutral SummaryArecor Therapeutics beats Redx Pharma on 7 of the 10 factors compared between the two stocks. Get Arecor Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for AREC and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart AREC vs. The Competition Export to ExcelMetricArecor TherapeuticsBiotechnology IndustryMedical SectorLON ExchangeMarket Cap£16.80M£127.96M£5.53B£2.96BDividend YieldN/A3.74%5.24%5.02%P/E Ratio-1.573.4027.64147.88Price / Sales2.784,084.30416.59258,917.23Price / Cash5.0713.1936.8927.97Price / Book2.6842.828.034.61Net Income-£10.68M-£92.79M£3.18B£5.90B7 Day Performance5.20%2.36%2.92%1.04%1 Month Performance1.51%2.53%3.72%5.12%1 Year Performance-62.92%189.23%35.14%80.82% Arecor Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ARECArecor TherapeuticsN/AGBX 44.50+2.3%N/A-62.5%£16.80M£6.04M-1.5710High Trading VolumeREDXRedx PharmaN/AN/AN/AN/A£58.35M£4.20M-150.00101Gap UpHigh Trading VolumeETXe-therapeuticsN/AN/AN/AN/A£52.59M£295K-450.0035News CoverageHigh Trading VolumeSBTXSkinBioTherapeuticsN/AGBX 16.80+1.1%N/A+78.4%£38.38M£1.56M-10.3311COSCollagen Solutions plc (COS.L)N/AN/AN/AN/A£30.99M£4.01M-8.283,350C4XDC4X DiscoveryN/AN/AN/AN/A£30.27M£24.68M300.0049High Trading VolumeDDDD4D pharmaN/AN/AN/AN/A£30.05M£718K-1.08106TRXTissue Regenix GroupN/AGBX 29.95+1.5%N/A-56.4%£27.00M£31.98M-30.92120News CoverageHigh Trading VolumeFUMFutura MedicalN/AGBX 7.60-9.8%N/A-78.5%£23.69M£8.68M-6.2712Gap DownOKYOOKYO PharmaN/AN/AN/AN/A£23.24MN/A-140.007News CoverageGap DownAORAorTech InternationalN/AN/AN/AN/A£19.99M£539K-33.383 Related Companies and Tools Related Companies Redx Pharma Alternatives e-therapeutics Alternatives SkinBioTherapeutics Alternatives Collagen Solutions plc (COS.L) Alternatives C4X Discovery Alternatives 4D pharma Alternatives Tissue Regenix Group Alternatives Futura Medical Alternatives OKYO Pharma Alternatives AorTech International Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:AREC) was last updated on 7/5/2025 by MarketBeat.com Staff From Our PartnersBanks aren’t ready for this altcoin—are you?Our expert analysts have identified a $100 billion gap in the crypto market. Only one project is perfectly ...Crypto 101 Media | SponsoredA new rule goes live in July — and the banks are quietly cashing inA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Arecor Therapeutics plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Arecor Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free AREC Stock Alerts